LAB
Standard BioTools·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
LAB fundamentals
Standard BioTools (LAB) released its earnings on Nov 4, 2025: revenue was 19.55M (YoY -56.52%), beat estimates; EPS was -0.09 (YoY -28.57%), missed estimates.
Revenue / YoY
19.55M
-56.52%
EPS / YoY
-0.09
-28.57%
Report date
Nov 4, 2025
EPS
Revenue
Revenue & Expenses
LAB has released its 2025 Q3 earnings report, with revenue of 19.55M, reflecting a YoY change of -11.47%, and net profit of -34.69M, showing a YoY change of -28.77%. The Sankey diagram below clearly presents LAB's revenue sources and cost distribution.
Key Indicators
Standard BioTools (LAB) key financial stats and ratios, covering profitability, financial health, and leverage.
Standard BioTools (LAB)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Standard BioTools (LAB)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Standard BioTools (LAB)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Standard BioTools (LAB) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Standard BioTools (LAB) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What factors drove the changes in Standard BioTools's revenue and profit?What were the key takeaways from Standard BioTools’s earnings call?What is Standard BioTools's gross profit margin?What is the market's earnings forecast for Standard BioTools next quarter?What does Standard BioTools do and what are its main business segments?What is the revenue and EPS growth rate for Standard BioTools year over year?What is Standard BioTools's latest dividend and current dividend yield?What were the key takeaways from Standard BioTools's earnings call?
